Skip to main content

WELLS FARGO & COMPANY/MN

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,585
-$1,406 QoQ
Shares Held
3,260
+13.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Jun 30, 2020
CallValue
$0
CallShares
0
PutValue
$5,000
PutShares
83

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. INO ranks #344 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,585 3,260
2026-03-31 $4,991 2,869
2025-12-31 $4,773 2,744
2025-09-30 $505 216
2025-06-30 $1,971 967
2025-03-31 $36,459 22,369
2024-12-31 $30,538 16,688
2024-09-30 $77,740 13,450
2024-06-30 $105,983 13,117
2024-03-31 $20,804 1,499
2023-12-31 $11,140 21,847
2023-09-30 $7,300 18,723
2023-06-30 $9,312 20,698
2023-03-31 $363,507 443,304
2022-12-31 $30,613 19,624
2022-09-30 $60,279 34,844
2022-06-30 $70,596 40,808
2022-03-31 $353,964 98,598
2021-12-31 $1,207,439 241,972
2021-09-30 $1,400,909 195,658
2021-06-30 $1,176,204 126,883
2021-03-31 $1,112,782 119,912
2020-12-31 $3,691,236 417,089
2020-09-30 $4,508,779 388,688
2020-06-30 $5,000 1,000
2020-06-30 $11,127,303 412,887
2020-03-31 $609,275 81,892